Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

BIOMARIN PHARMACEUTICAL INC (BMRN)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20
   8-K10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income   54.139.3-64.110.8832.1790.0854.0
Depreciation and amortization   105.4107.4108.0109.4109.2107.2105.2
Stock-based compensation   187.8195.6197.3201.0202.1192.2189.7
Deferred taxes   -13.4-14.1-15.6-47.8-882.9-897.3-890.0
Change in working capital   [+] -109.1-72.272.611.0-75.7-55.4-195.9
Other operating activities   -105.8-110.46.3-4.48.71.7-53.2
Cash from operations   119.0145.6304.5280.0269.1214.185.4
   
Capital expenditures   -103.4-98.9-95.6-97.9-95.7-99.3-114.3
Purchases of intangible assets   -20.0-22.8-23.6-16.9-18.8-22.5-23.2
Purchases of short-term investments   484.6574.4484.6117.4321.7-197.10.0
Other cash from investing   -478.3-660.5-731.7-302.5-280.5117.083.9
Cash from investing   -117.2-207.7-366.3-299.9-73.3-201.8-53.6
   
Option exercises   51.051.649.244.552.667.671.9
Other cash from financing   27.450.649.1-336.1-323.7294.0303.0
Cash from financing   -23.7-1.00.0-380.6-376.3176.4181.1
   
Free cash flow   15.646.7209.0182.1173.4114.8-28.9
        Per share (diluted)   $0.08$0.25$1.14$0.98$0.91$0.61($0.15)
   
Cash paid for interest   10.310.410.413.213.212.212.2

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy